A detailed history of Deutsche Bank Ag\ transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 49,549 shares of CORT stock, worth $3.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,549
Previous 38,930 27.28%
Holding current value
$3.32 Million
Previous $1.26 Million 81.33%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$29.51 - $46.26 $313,366 - $491,234
10,619 Added 27.28%
49,549 $2.29 Million
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $285,887 - $443,826
-12,872 Reduced 24.85%
38,930 $1.26 Million
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $158,756 - $206,609
7,524 Added 16.99%
51,802 $1.3 Million
Q4 2023

Feb 14, 2024

SELL
$24.82 - $32.88 $17,051 - $22,588
-687 Reduced 1.53%
44,278 $1.44 Million
Q3 2023

Nov 09, 2023

BUY
$21.97 - $33.8 $112,793 - $173,529
5,134 Added 12.89%
44,965 $1.23 Million
Q2 2023

Aug 14, 2023

SELL
$21.44 - $25.15 $488,681 - $573,243
-22,793 Reduced 36.4%
39,831 $886,000
Q1 2023

May 15, 2023

BUY
$19.2 - $24.47 $336,019 - $428,249
17,501 Added 38.79%
62,624 $1.36 Million
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $133,086 - $199,863
6,671 Added 17.35%
45,123 $916,000
Q3 2022

Nov 14, 2022

SELL
$24.7 - $29.12 $231,142 - $272,504
-9,358 Reduced 19.57%
38,452 $986,000
Q2 2022

Aug 11, 2022

SELL
$17.33 - $25.3 $175,587 - $256,339
-10,132 Reduced 17.49%
47,810 $1.14 Million
Q1 2022

May 13, 2022

SELL
$16.53 - $25.21 $176,342 - $268,940
-10,668 Reduced 15.55%
57,942 $1.31 Million
Q4 2021

Feb 11, 2022

SELL
$17.1 - $23.34 $5.15 Million - $7.03 Million
-301,217 Reduced 81.45%
68,610 $1.36 Million
Q3 2021

Nov 04, 2021

SELL
$19.68 - $22.53 $433,884 - $496,718
-22,047 Reduced 5.63%
369,827 $7.28 Million
Q2 2021

Aug 11, 2021

BUY
$19.97 - $24.43 $372,859 - $456,132
18,671 Added 5.0%
391,874 $8.62 Million
Q1 2021

May 13, 2021

SELL
$23.49 - $30.56 $832,180 - $1.08 Million
-35,427 Reduced 8.67%
373,203 $8.88 Million
Q4 2020

Feb 16, 2021

SELL
$16.78 - $27.3 $1.71 Million - $2.79 Million
-102,111 Reduced 19.99%
408,630 $10.7 Million
Q3 2020

Nov 12, 2020

SELL
$12.46 - $19.98 $4.77 Million - $7.65 Million
-382,867 Reduced 42.85%
510,741 $8.89 Million
Q2 2020

Aug 13, 2020

BUY
$11.0 - $18.26 $110,693 - $183,750
10,063 Added 1.14%
893,608 $15 Million
Q1 2020

May 14, 2020

BUY
$10.11 - $14.04 $8.31 Million - $11.5 Million
821,578 Added 1325.83%
883,545 $10.5 Million
Q4 2019

Feb 14, 2020

SELL
$12.06 - $16.96 $1.15 Million - $1.61 Million
-95,144 Reduced 60.56%
61,967 $748,000
Q3 2019

Nov 14, 2019

SELL
$10.41 - $14.66 $833,893 - $1.17 Million
-80,105 Reduced 33.77%
157,111 $2.22 Million
Q2 2019

Aug 14, 2019

BUY
$9.78 - $12.76 $740,531 - $966,174
75,719 Added 46.89%
237,216 $2.64 Million
Q1 2019

May 15, 2019

BUY
$10.03 - $15.71 $170,038 - $266,331
16,953 Added 11.73%
161,497 $1.89 Million
Q4 2018

Feb 14, 2019

SELL
$11.29 - $17.19 $2.83 Million - $4.3 Million
-250,432 Reduced 63.4%
144,544 $1.93 Million
Q3 2018

Dec 21, 2021

BUY
$12.27 - $15.65 $844,556 - $1.08 Million
68,831 Added 21.1%
394,976 $5.54 Million
Q3 2018

Nov 14, 2018

SELL
$12.27 - $15.65 $2.01 Million - $2.57 Million
-164,063 Reduced 33.47%
326,145 $4.57 Million
Q2 2018

Apr 21, 2020

BUY
$15.3 - $19.69 $3 Million - $3.86 Million
195,870 Added 66.55%
490,208 $7.71 Million
Q2 2018

Aug 14, 2018

SELL
$15.3 - $19.69 $7.45 Million - $9.59 Million
-487,242 Reduced 62.34%
294,338 $4.63 Million
Q1 2018

Oct 18, 2019

BUY
$14.59 - $25.5 $3.73 Million - $6.52 Million
255,516 Added 48.57%
781,580 $12.9 Million
Q1 2018

May 15, 2018

BUY
$14.59 - $25.5 $4.39 Million - $7.68 Million
300,989 Added 133.73%
526,064 $8.65 Million
Q4 2017

Feb 14, 2018

BUY
$15.77 - $20.72 $84,716 - $111,307
5,372 Added 2.45%
225,075 $4.06 Million
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $2.7 Million - $4.24 Million
219,703
219,703 $4.24 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.17B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.